These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7557949)

  • 1. Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.
    Ariza A; López D; Mate JL; Isamat M; Musulén E; Pujol M; Ley A; Navas-Palacios JJ
    Hum Pathol; 1995 Oct; 26(10):1144-7. PubMed ID: 7557949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 expression in human gliomas.
    Ranuncolo SM; Ladeda V; Specterman S; Varela M; Lastiri J; Morandi A; Matos E; Bal de Kier Joffé E; Puricelli L; Pallotta MG
    J Surg Oncol; 2002 Jan; 79(1):30-5; discussion 35-6. PubMed ID: 11754374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.
    Fernández-Figueras MT; Ariza A; Calatrava A; Puig L; Fernández-Vasalo A; Ferrándiz C
    J Cutan Pathol; 1996 Apr; 23(2):133-9. PubMed ID: 8721447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of variant CD44 epitopes in human astrocytic brain tumors.
    Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
    J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
    Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
    Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
    Li H; Hamou MF; de Tribolet N; Jaufeerally R; Hofmann M; Diserens AC; Van Meir EG
    Cancer Res; 1993 Nov; 53(22):5345-9. PubMed ID: 7693337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in human meningiomas: An immunocytochemical, immunohistochemical and flow cytometric analysis.
    Rooprai HK; Liyanage K; King A; Davies D; Martin K; Pilkington GJ
    Int J Oncol; 1999 May; 14(5):855-60. PubMed ID: 10200334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression.
    Ge L; Resnick NM; Ernst LK; Salvucci LA; Asman DC; Cooper DL
    J Neurooncol; 1995 Dec; 26(3):251-7. PubMed ID: 8750191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
    Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
    Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 expression in metastatic and non-metastatic non-small cell lung cancers.
    Kargi HA; Kuyucuoğlu MF; Alakavuklar M; Akpinar O; Erk S
    Cancer Lett; 1997 Oct; 119(1):27-30. PubMed ID: 18372518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
    Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
    J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.